Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Discovery & Development Formulation, Contract Development Services, Small Molecules, Ingredients, Contract Manufacturing Services

Let the Molecule Decide

Every molecule – large and small – has a structure that drives its physicochemical and biopharmaceutical characteristics – and its potential as an active ingredient. The smoothest path to market lies in understanding your molecule’s characteristics and applying strategies to overcome any deficiencies as early as possible. With sound expertise and judgment, physicochemical properties, such as the molecule’s solubility, permeability, and stability, can be evaluated at the early stages of development – and from there, you can make decisions about the best formulation approach and what the molecule needs to help it become a commercial success.

Of all the decisions made at the early preclinical stages of oral drug development, there are two that are perhaps the most fundamental. The first is to select the nature of the potential API and its form (salt and polymorph), which requires proper physical characterization and optimization of the API manufacturing process. The second is to select an appropriate drug delivery system, with improved solubility and bioavailability usually being key criteria.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Stephen Tindal and Ronak Savla

Stephen Tindal is Director of Science & Technology, and Ronak Savla is Scientific Affairs Manager, both at Catalent Pharma Solutions, New Jersey, USA.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register